A double-pronged attack on malignant B cells with improved immunotherapy

Multiple myeloma, a cancer of the bone marrow, remains difficult to treat despite modern CAR T cell therapies. In recent research, a team led by Dr. Armin Rehm presents an improved immunotherapy that recognizes two distinct features of malignant cells to destroy the cancer more effectively.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup